ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

ANI Pharmaceuticals, Inc. has a 1-year low of $52.50 and a 1-year high of $70.81. ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) last posted its quarterly earnings data on Friday, November 8th.

After hours: February 12 at 5:24:15 PM EST Loading Chart for ANIP ...

17:08 EST Recursion Pharmaceuticals (RXRX) files automatic mixed securities shelf Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make ...

Deutsche Bank initiated coverage of Xenon Pharmaceuticals (XENE) with a Buy rating and $67 price target Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top ...

After hours: February 10 at 4:30:26 p.m. EST Loading Chart for ANIP ...

Sandeep Jain, Managing Director, stated, “We continue to be the manufacturing partners of choice for pharmaceutical companies ... The above press release has been provided by VMPL. ANI will not be ...

A group of former leaders from health comms giant Inizio Evoke have come together to launch Flex Marketing, a new agency ...

As millions gather for the Maha Kumbh 2025, Coca-Cola India is strengthening its commitment to local communities through a dynamic retail network, employment generation, and women's entrepreneurship.

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...